0001209191-16-129222.txt : 20160622
0001209191-16-129222.hdr.sgml : 20160622
20160622162120
ACCESSION NUMBER: 0001209191-16-129222
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160621
FILED AS OF DATE: 20160622
DATE AS OF CHANGE: 20160622
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIND Therapeutics, Inc
CENTRAL INDEX KEY: 0001385228
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 325 VASSAR STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 6174913400
MAIL ADDRESS:
STREET 1: 325 VASSAR STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
FORMER COMPANY:
FORMER CONFORMED NAME: BIND Biosciences, Inc
DATE OF NAME CHANGE: 20130130
FORMER COMPANY:
FORMER CONFORMED NAME: BIND Biosciences Inc
DATE OF NAME CHANGE: 20070105
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LYNCH DANIEL
CENTRAL INDEX KEY: 0001177082
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36072
FILM NUMBER: 161726794
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2016-06-21
0
0001385228
BIND Therapeutics, Inc
BIND
0001177082
LYNCH DANIEL
C/O BIND THERAPEUTICS, INC.
325 VASSAR STREET
CAMBRIDGE
MA
02139
1
0
0
1
Chairman
Employee Stock Option (Right to Buy)
0.44
2016-06-21
4
A
0
20000
0.00
A
2026-06-20
Common Stock
20000
20000
D
Vests and becomes exercisable in full on the earlier of (i) the first anniversary of the date of grant or (ii) immediately prior to the next annual meeting of the Company's stockholders after the date of grant, subject to the Reporting Person's continued service as a member of the Board of Directors of the Issuer through the applicable vesting date.
/s/ Andrew Hirsch, Attorney-in-Fact for Daniel Lynch
2016-06-22